Chemotherapy News and Research

Latest Chemotherapy News and Research

Breast cancer sufferers experience more side effects from chemo than previously thought

Women with breast cancer ages 64 and younger experience three to four times more serious side effects from chemotherapy than previously hypothesized, according to a study published in the Aug. 16 edition of the Journal of the National Cancer Institute, the AP/Philadelphia Inquirer reports.

16 Aug 2006

Cancer patient receives first proton therapy treatment

A Cocoa Beach man with prostate cancer has become the first patient to undergo treatment at the new University of Florida Proton Therapy Institute, the first time the most advanced form of radiation therapy available has been offered in the Southeast.

15 Aug 2006

Breast cancer 'wonder drug' Herceptin carries a risk for heart problems

According to the latest research breast cancer wonder drug Herceptin puts some women at risk of heart problems.

15 Aug 2006

Cancer stem cells spur glioma angiogenesis, could hold key to brain tumor therapy

Stem cell-like glioma cancer cells that share many characteristics with normal stem cells propel the lethal growth of brain cancers by promoting tumor blood vessel formation, and may hold the key to treating these deadly cancers.

15 Aug 2006

Gene test for cancers could mean more effective, tailored-made treatment

Scientists in the United States have developed a test which is able to predict which lung cancer tumours are most likely to recur.

14 Aug 2006

Little known about the impacts of cancer on the Australian workforce

Thirty seven thousand Australians aged 20-64 years of age were diagnosed with cancer in 2001 yet surprisingly little is known about the impacts of cancer on the Australian workforce.

8 Aug 2006

New method of delivering a dose of radioactive iodine

A new method of delivering a dose of radioactive iodine - using a man-made version of scorpion venom as a carrier - targets deadly brain tumors called gliomas without affecting neighboring tissue or body organs.

7 Aug 2006

Txr1 gene that affects human cancer cells' sensitivity to chemotherapy

Gene that affects human cancer cells' sensitivity to chemotherapy - an important finding in the effort to increase the effectiveness of chemotherapy.

6 Aug 2006

Turning the immune system against cancer

Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays.

4 Aug 2006

Trial of Topotecan following Carboplatin and Paclitaxel in treatment of ovarian cancer

The drug topotecan does not increase survival for ovarian cancer patients when used with standard chemotherapy in first-line treatment and is not recommended for future use.

2 Aug 2006

Do close surgical margins predict if breast cancer will return?

Cancer cells present after additional surgery for breast cancer may predict whether a woman will see her cancer return.

1 Aug 2006

'Scorpion venom' zaps aggressive brain tumours

Researchers in the U.S. have come up with a "man-made" scorpion venom which they say targets deadly brain tumours called gliomas without affecting neighboring tissue or body organs.

31 Jul 2006

Smart cancer drug on sale in the UK

A new "smart" cancer drug will be available to patients in Britain today which works by deploying two chemical 'bullets' that attack specific molecular targets, starving tumours of nutrients and inhibiting the enzyme that signals cells to multiply.

31 Jul 2006

Heat treatment may zap cancer cells

Scientists believe they have discovered a clue as to why so many men with testicular cancer survive against the odds.

26 Jul 2006

Combining chemotherapy with radiation therapy after the surgical removal of cancer in the pancreas improves survival

Patients with pancreatic cancer, a historically difficult-to-treat cancer with poor survival rates, may benefit from treatments studied in an international, multi-center research trial.

26 Jul 2006

Heat sensitivity may make testicular cancer cells more susceptible to standard treatments and die off more readily

Experts at Johns Hopkins have linked scientific evidence spanning more than 30 years to suggest an explanation for why testicular cancer patients like seven-time Tour de France winner Lance Armstrong survive far better than patients with other advanced cancers.

26 Jul 2006